Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.58 |
| ▸ | RXFP1 | Q9HBX9 | 3/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.51 |
| ▸ | ADORA2B | P29275 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2704481 | 0.78 | KMT2A (0.59) | KMT2ARXFP1CYP2C19MAPK1ADORA2A | |
| SCHEMBL28223972 | 0.76 | KMT2A (0.58) | KMT2ARXFP1CYP2C19MAPK1ADORA2A | |
| SCHEMBL2501268 | 0.76 | RXFP1 (0.59) | KMT2ARXFP1CYP2C19MAPK1ADORA2A | |
| SCHEMBL5454084 | 0.76 | TSHR (0.67) | KMT2ARXFP1CYP2C19MAPK1ADORA2A | |
| SCHEMBL10407513 | 0.76 | KMT2A (0.58) | KMT2ARXFP1CYP2C19MAPK1ADORA2A | |
| SCHEMBL569368 | 0.76 | KMT2A (0.58) | KMT2ARXFP1CYP2C19MAPK1ADORA2A | |
| SCHEMBL2496142 | 0.76 | CYP2C19 (0.61) | KMT2ARXFP1CYP2C19MAPK1ADORA2A | |
| SCHEMBL9123418 | 0.76 | CYP2C19 (0.59) | KMT2ARXFP1CYP2C19MAPK1ADORA2A | |
| SCHEMBL9067375 | 0.76 | KMT2A (0.58) | KMT2ARXFP1CYP2C19MAPK1ADORA2A | |
| SCHEMBL18112644 | 0.76 | KMT2A (0.53) | KMT2ARXFP1CYP2C19MAPK1ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111616995-A | Coffee silverskin extract and preparation method and application thereof | 云南英格生物技术有限公司 | 2020-09-04 | — | — | CN | claimed |
| CN-113412226-B | Structural construction of a composite material capsule and reinforcing base | 诺威德尔塔咖啡贸易工业有限公司 | 2023-04-18 | — | — | CN | disclosed |
| CN-113412226-A | Structural construction of a composite material capsule and reinforcing base | 诺威德尔塔咖啡贸易工业有限公司 | 2021-09-17 | — | — | CN | disclosed |
| CN-111616995-A | Coffee silverskin extract and preparation method and application thereof | 云南英格生物技术有限公司 | 2020-09-04 | — | — | CN | disclosed |
| US-20160030476-A1 | Compositions, Methods And Devices For Promoting Wound Healing And Reducing Infection | IASIS MOLECULAR SCIENCES (US) | 2016-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160030476-A1 | Compositions, Methods And Devices For Promoting Wound Healing And Reducing Infection | MMP8, IL1B, MMP1 | KMT2A 4653/4885RXFP1 1779/4885CYP2C19 1421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.